drugset / Trial / NCT06773117

Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

NCT06773117 ↗

Phase 3 Not yet recruiting 360 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To confirm the effect of Susu Xiaoer Zhike granules in treating cough caused by common cold (wind-cold cough Syndromes) in children aged 6\~13 years, shortening the course of disease and improving symptoms.

Timeline

Start
2025-09-01
Primary completion
2027-05-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Susu Xiao'er Zhike Granules Traditional medicine (herbal / TCM) 1.01 g —
Subject Susu Xiao'er Zhike Granules Traditional medicine (herbal / TCM) 20.25 g —

Indications

No indication recorded.